Tuberculosis of adrenal glands
ICD-10 A18.7 is a billable code used to indicate a diagnosis of tuberculosis of adrenal glands.
Tuberculosis of the adrenal glands is a rare but serious manifestation of extrapulmonary tuberculosis, which occurs when Mycobacterium tuberculosis infects the adrenal glands. This condition can lead to adrenal insufficiency due to the destruction of adrenal tissue. Patients may present with nonspecific symptoms such as fatigue, weight loss, fever, and abdominal pain. In some cases, adrenal tuberculosis can cause hyperpigmentation of the skin due to increased adrenocorticotropic hormone (ACTH) levels. Diagnosis typically involves imaging studies such as CT scans or MRIs, which may reveal adrenal enlargement or calcification, and microbiological tests including sputum culture or biopsy of the adrenal gland. Treatment usually consists of a multi-drug regimen of antitubercular medications, which may need to be adjusted based on drug susceptibility testing. Monitoring for treatment efficacy and potential side effects is crucial, as is addressing any adrenal insufficiency that may arise. Public health considerations include contact tracing and isolation procedures for active cases, as well as monitoring for drug resistance, which can complicate treatment and increase transmission risk.
Detailed records of diagnostic tests, treatment regimens, and follow-up care.
Patients presenting with systemic symptoms and suspected extrapulmonary tuberculosis.
Awareness of drug resistance patterns and public health reporting requirements.
Assessment of adrenal function and management of adrenal insufficiency.
Patients with adrenal crisis or symptoms of adrenal insufficiency.
Coordination with infectious disease specialists for comprehensive care.
Used when a biopsy is performed to confirm adrenal tuberculosis.
Pathology report detailing findings and confirmation of tuberculosis.
Involvement of both infectious disease and pathology specialists.
Common symptoms include fatigue, weight loss, abdominal pain, fever, and skin hyperpigmentation due to adrenal insufficiency.
Diagnosis typically involves imaging studies, microbiological tests, and sometimes biopsy of the adrenal gland to confirm the presence of Mycobacterium tuberculosis.
Treatment usually consists of a multi-drug regimen of antitubercular medications, and management of any adrenal insufficiency that may arise.
Public health measures include contact tracing, isolation of active cases, and monitoring for drug resistance to prevent further transmission.
